Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%)
< Home < Back

USFDA completes audit at Dr. Reddy's Louisiana Plant

Date: 22-02-2019

The US Food and Drug Administration (USFDA) has completed audit at Dr. Reddy's Laboratories’ Formulations Shreveport Plant, Louisiana, USA with one observation.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.